Retraction
Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2
Paper Information
Record ID:
38498
Author(s):
Journal:
Publication Date:
April 20, 2020
Retraction Date:
August 04, 2022
(3.3 years years ago)
Subjects:
Institutions:
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Elsevier - Cell Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (81)
81
Total Citations20
Post-Retraction(24.7%)
61
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
13
Within 1 year
1
After 2+ years
757
Days since retraction (latest)
Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells
Sunday Okutachi, Ganesh babu Manoharan, Daniel Abankwa
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2021
413 days before retraction
Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials
E. Elizabeth Patton, Leonard I. Zon, David M. Langenau
Nature Reviews Drug Discovery
Open Access
Published: Jun 2021
391 citations
391 citations
419 days before retraction
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning
Yavar Shiravand, Ulrich Walter, Kerstin Jurk
Hämostaseologie
Published: Jun 2021
9 citations
9 citations
429 days before retraction
Caracterização da interação da proteína TIPRL com fosfatases tipo 2A em cultura de células
Ana Amélia Sanchez Iacia
Unknown Journal
Open Access
Published: May 2021
436 days before retraction
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
Stephin J. Vervoort, Sarah A. Welsh, Jennifer R. Devlin et al. (33 authors)
Cell
Open Access
Published: May 2021
171 citations
171 citations
444 days before retraction
Protein phosphatases in the RNAPII transcription cycle: erasers, sculptors, gatekeepers, and potential drug targets
Giacomo Cossa, Pabitra K. Parua, Martin Eilers et al. (4 authors)
Genes & Development
Open Access
Published: Apr 2021
60 citations
60 citations
469 days before retraction
Druggable cancer phosphatases
Julia P. Vainonen, Majid Momeny, Jukka Westermarck
Science Translational Medicine
Published: Apr 2021
93 citations
93 citations
484 days before retraction
The Key Role of the Phosphatase PP2A in the Development of Acute Myeloid Leukemia
Javier Marco, Irene Peris, Carmen Vicente et al. (4 authors)
IntechOpen eBooks
Open Access
Published: Mar 2021
498 days before retraction
Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer
Jaime Rubio, Ion Cristóbal, Andrea Santos et al. (10 authors)
Cancers
Open Access
Published: Mar 2021
13 citations
13 citations
500 days before retraction
Pack a STRIPAK with hubs inside a hub
Wei Huang, Daniel Léonard, Derek J. Taylor
Nature Structural & Molecular Biology
Open Access
Published: Mar 2021
7 citations
7 citations
521 days before retraction
PPP6C negatively regulates oncogenic ERK signaling through dephosphorylation of MEK
Eunice Cho, Hua Jane Lou, Leena Kuruvilla et al. (5 authors)
Cell Reports
Open Access
Published: Mar 2021
25 citations
25 citations
521 days before retraction
Phosphorylation state of the histone variant H2A.X controls human stem and progenitor cell fate decisions
Luca Orlando, Borko Tanasijevic, Mio Nakanishi et al. (13 authors)
Cell Reports
Open Access
Published: Mar 2021
20 citations
20 citations
521 days before retraction
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Ylenia Cicirò, Arturo Sala
Oncogenesis
Open Access
Published: Feb 2021
138 citations
138 citations
524 days before retraction
A conserved allosteric element controls specificity and activity of functionally divergent PP2C phosphatases from Bacillus subtilis
Laurent Blanchoin, Niels Bradshaw
Journal of Biological Chemistry
Open Access
Published: Jan 2021
10 citations
10 citations
580 days before retraction
Sensitization of FOLFOX-Resistant Colorectal Cancer Cells via the Modulation of a Novel Pathway Involving Protein Phosphatase 2A
Satya Narayan, Asif Raza, Iqbal Mahmud et al. (8 authors)
SSRN Electronic Journal
Open Access
Published: Jan 2021
580 days before retraction
Competition between two phosphatases fine-tunes Hedgehog signaling
Min Liu, Aiguo Liu, Jie Wang et al. (7 authors)
The Journal of Cell Biology
Open Access
Published: Dec 2020
8 citations
8 citations
583 days before retraction
Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
You Jung Kang, Yen N. Diep, Minh Tran et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2020
31 citations
31 citations
596 days before retraction
Reeling in the Zebrafish Cancer Models
Alicia M. McConnell, Haley R. Noonan, Leonard I. Zon
Annual Review of Cancer Biology
Open Access
Published: Dec 2020
18 citations
18 citations
609 days before retraction
The Serine/Threonine Protein Phosphatase 2A (PP2A) Regulates Syk Activity in Human Platelets
Stephanie Makhoul, Elena Kumm, Pengyu Zhang et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2020
9 citations
9 citations
617 days before retraction
Kinases/Phosphatases | Serine/Threonine Protein Phosphatases
Veerle Janssens
Elsevier eBooks
Published: Nov 2020
4 citations
4 citations
623 days before retraction
Phosphoproteomic Effects of Acute Depletion of PP2A Regulatory Subunit Cdc55
Michael Plank, Marina Berti, Robbie Loewith
PROTEOMICS
Published: Sep 2020
4 citations
4 citations
679 days before retraction
PPP6C negatively regulates oncogenic ERK signaling through dephosphorylation of MEK
Eunice Cho, Hua Jane Lou, Leena Kuruvilla et al. (5 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2020
1 citation
1 citation
684 days before retraction
Protein phosphatase 1 in tumorigenesis: is it worth a closer look?
Juliana Felgueiras, Cármen Jerónimo, Margarida Fardilha
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Sep 2020
33 citations
33 citations
684 days before retraction
MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential
Rachel Bayley, Ciara Ward, Paloma García
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Aug 2020
52 citations
52 citations
709 days before retraction
Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy
Vibha Singh, Siddhant Bhoir, Rupesh V. Chikhale et al. (8 authors)
iScience
Open Access
Published: Aug 2020
40 citations
40 citations
714 days before retraction
Selective Activation of Protein Phosphatase 2A Complexes
Unknown Authors
Synfacts
Published: Aug 2020
716 days before retraction
Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer
Yang Tang, Ge‐Min Fang, Fenghua Guo et al. (19 authors)
Cancer Cell
Open Access
Published: Jun 2020
108 citations
108 citations
770 days before retraction
2. Adding perphenazine to increase effectiveness of standard glioblastoma chemoirradiation.
Richard E. Kast
Authorea (Authorea)
Open Access
Published: Jun 2020
6 citations
6 citations
773 days before retraction
Selective stabilization supports phosphatase targeting in cancer
Joseph Willson
Nature Reviews Drug Discovery
Published: May 2020
815 days before retraction
Piecing Together a Broken Tumor Suppressor Phosphatase for Cancer Therapy
Jukka Westermarck, Benjamin G. Neel
Cell
Open Access
Published: Apr 2020
28 citations
28 citations
855 days before retraction
Quick Stats
Total Citations:
81
Years Since Retraction:
3.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025